Summit Securities Group’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$115K Buy
1,599
+1,529
+2,184% +$144K 0.01% 360
2026
Q1
$8.28K Sell
70
-584
-89% -$72.2K ﹤0.01% 701
2025
Q4
$82.3K Sell
654
-111
-15% -$14.5K 0.01% 510
2025
Q3
$112K Buy
765
+465
+155% +$70.3K 0.02% 369
2025
Q2
$46.8K Sell
300
-88
-23% -$14K 0.01% 533
2025
Q1
$63.9K Buy
+388
New +$64.5K 0.01% 299
2023
Q3
Sell
-605
Closed -$104K 1080
2023
Q2
$104K Sell
605
-310
-34% -$53.6K 0.01% 287
2023
Q1
$152K Sell
915
-5,054
-85% -$828K 0.01% 242
2022
Q4
$875K Buy
5,969
+5,704
+2,152% +$844K 0.03% 180
2022
Q3
$39K Sell
265
-720
-73% -$120K ﹤0.01% 643
2022
Q2
$169K Buy
985
+791
+408% +$137K 0.02% 327
2022
Q1
$37K Buy
+194
New +$38.4K ﹤0.01% 648

Other funds holding ZTS

Summit Securities Group's ZTS Position: Q2 2026 in Review

Summit Securities Group increased its Zoetis (ZTS) stake by 2,184% in Q2 2026, buying an estimated $144K and bringing the position to 1,599 shares worth $115K. The position accounts for 0.01% of the portfolio, ranked #360.

Summit Securities Group first reported a position in ZTS in Q1 2022 and has held it in 12 quarters since. The position peaked at $875K in Q4 2022. 1,429 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Summit Securities Group held 1,599 shares of Zoetis worth $115K as of Q2 2026.
  • Summit Securities Group bought 1,529 Zoetis shares in Q2 2026, an estimated $144K.
  • Zoetis made up 0.01% of Summit Securities Group's portfolio in Q2 2026, its #360 holding.
  • Summit Securities Group first reported a position in Zoetis in Q1 2022 and has held it in 12 quarters since.
  • Summit Securities Group's Zoetis position peaked at $875K in Q4 2022.
  • 1,429 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Summit Securities Group's 13F filing for Q2 2026, filed 3 Aug 2026.